CEA Grants NEB License to Patent that Covers a Process for Synthesis of Double Stranded RNA
News Feb 28, 2006
The CEA, a French government-funded research organisation, has announced that its life science division has granted New England Biolabs Inc. a non-exclusive license under the patent family EP10618966.
This license concerns some RNAi products that NEB supplies to its customers in the research reagent field.
This patent family, owned solely by the CEA, covers a process for an enzymatic synthesis of double-stranded RNA based on the transcription of a double-stranded DNA template.
The American Society of Human Genetics (ASHG), along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants when new findings emerge that suggest their genetic information should be interpreted differently, which would allow participants to benefit from current genomics advances.READ MORE